A detailed history of Verition Fund Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 40,815 shares of EXAS stock, worth $2.16 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
40,815
Previous 4,926 728.56%
Holding current value
$2.16 Million
Previous $208,000 1236.06%
% of portfolio
0.02%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $1.52 Million - $2.54 Million
35,889 Added 728.56%
40,815 $2.78 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $13,514 - $24,283
327 Added 7.11%
4,926 $208,000
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $20,032 - $26,262
356 Added 8.39%
4,599 $317,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $250,591 - $321,279
4,243 New
4,243 $313,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $302,054 - $458,045
-4,819 Reduced 60.24%
3,181 $298,000
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $377,520 - $566,160
8,000 New
8,000 $542,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $367,175 - $567,014
11,485 Added 61.59%
30,133 $979,000
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $501,922 - $1.07 Million
14,095 Added 309.58%
18,648 $735,000
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $22,448 - $32,190
390 Added 9.37%
4,553 $318,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $74,385 - $103,297
1,026 Added 32.71%
4,163 $324,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $283,082 - $389,144
3,137 New
3,137 $299,000
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $1.81 Million - $2.54 Million
-24,861 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $151,194 - $251,538
2,712 Added 12.24%
24,861 $2.16 Million
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $839,447 - $2.31 Million
22,149 New
22,149 $1.29 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $477,997 - $613,899
-6,155 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $556,227 - $753,925
6,155 New
6,155 $556,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $780,885 - $1.03 Million
-8,724 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $540,713 - $841,866
8,724 New
8,724 $756,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $725,942 - $1.07 Million
-12,954 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$48.29 - $80.6 $97,062 - $162,006
2,010 Added 18.37%
12,954 $1.02 Million
Q2 2018

Aug 15, 2018

BUY
$37.84 - $69.96 $414,120 - $765,642
10,944 New
10,944 $654,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.